National / Science & Health Apr 19, 2022
Distribution of Novavax vaccines to local governments are expected to start in late May, the health ministry said.
World Dec 21, 2021
It is not clear yet how Novavax performs against the omicron variant, or whether a booster dose will be needed.
National Sep 7, 2021
Known as TAK-019 in Japan, the vaccine has proved to be 90% effective in preventing infections at clinical trials held abroad.
Commentary / World Jun 19, 2021
A vaccine the world badly needs looks better than ever
by Max Nisen
The vaccine is also more stable and easily stored than mRNA vaccines, which will be helpful in broad distribution.
World Jun 15, 2021
Novavax COVID-19 shot highly effective against variants in trial
by Todd Gillespie and Robert Langreth
The company plans to apply for regulatory clearance globally, with much of the first available doses going to low- and middle-income countries.
National / Science & Health Feb 24, 2021
Takeda starts clinical trial of Novavax COVID-19 vaccine in Japan
The drugmaker said it expects to gain results from a study on 200 Japanese participants age 20 or older in the second half of this year.
World Jan 29, 2021
COVID-19 vaccine 89.3% effective in U.K. trial but less so in South Africa, Novavax says
The U.S. company believes the vaccine was 85.6% effective against the highly transmissible U.K. variant, which was also circulating during the study.
World / Science & Health Jan 20, 2021
South Korea in talks to secure 40 million doses of Novavax vaccine
South Korea is in talks to purchase 40 million doses of a coronavirus vaccine developed by Novavax, its local manufacturer SK Bioscience said Wednesday. The deal, if agreed, will boost supply of COVID-19 vaccines in the country to 146 million doses, more than enough for ...